Answers are grounded in this paper and cite their sources.
Background The serum uric acid-to-creatinine ratio (UCR), an indicator of renal function, has been linked to adverse cardiovascular outcomes. This study aimed to evaluate the association between UCR and the risk of all-cause mortality in patients with coronary heart disease (CHD). Methods This longitudinal cohort study included patients with CHD who were admitted to the First Affiliated Hospital of Shantou University Medical College between January 2020 and April 2024. Restricted cubic spline (RCS) analysis, multivariate Cox regression models, and threshold effect analyses were used to assess the association between UCR and mortality risk. Results A total of 5,850 patients with CHD were included, with a mean age of 66.5 ± 10.9 years. During a median follow-up period of 487.5 days (interquartile range [IQR]: 240–833), 501 (8.6%) deaths occurred. RCS analysis revealed a U-shaped relationship between UCR and all-cause mortality risk, with patients having a UCR range of 3.5 to 6.5 showing the lowest mortality risk. Multivariate Cox regression models indicated that patients with UCR < 3.5 had a 46% higher mortality risk (HR = 1.46, 95% CI: 1.18–1.81), while those with UCR ≥ 6.5 had a 56% higher mortality risk (HR = 1.56, 95% CI: 1.13–2.15). A negative association between UCR and all-cause mortality risk was observed in patients with UCR < 4.418 (HR = 0.77, 95% CI: 0.68–0.88), whereas a positive association was observed in those with UCR ≥ 4.418 (HR = 1.21, 95% CI: 1.06–1.38). Conclusion A U-shaped relationship was observed between UCR and all-cause mortality risk in patients with CHD. The findings suggest that UCR may serve as a prognostic indicator of CHD.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: